Advertisement
UK markets close in 5 hours 33 minutes

  • FTSE 100

    7,870.93
    +22.94 (+0.29%)
     

  • FTSE 250

    19,412.11
    +71.97 (+0.37%)
     

  • AIM

    744.38
    +1.26 (+0.17%)
     

  • GBP/EUR

    1.1686
    +0.0019 (+0.16%)
     

  • GBP/USD

    1.2471
    +0.0015 (+0.12%)
     

  • Bitcoin GBP

    49,387.45
    -1,425.18 (-2.80%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • CRUDE OIL

    82.05
    -0.64 (-0.77%)
     

  • GOLD FUTURES

    2,394.60
    +6.20 (+0.26%)
     

  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     

  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     

  • DAX

    17,773.35
    +3.33 (+0.02%)
     

  • CAC 40

    8,014.98
    +33.47 (+0.42%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

Dynavax Technologies (DVAX) Catches Eye: Stock Gains 6.6%

Zacks Equity Research
Updated

Dynavax Technologies Corporation DVAX was a big mover last session, as the company saw its shares rise almost 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 60% in the past one-month time frame.

The company has seen no positive or negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate remained unchanged over the same timeframe. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Dynavax Technologies currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

Dynavax Technologies Corporation Price

 

Dynavax Technologies Corporation Price | Dynavax Technologies Corporation Quote

ADVERTISEMENT

A better-ranked stock in the Medical - Biomedical and Genetics industry is Aimmune Therapeutics, Inc. AIMT holding a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is DVAX going up? Or down? Predict to see what others think:  Up or Down

Zacks' Hidden Trades

While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?                                                                                                                                                                                                                                                              

Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trade>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Click for Free Dynavax Technologies Corporation (DVAX) Stock Analysis Report >>
 
Click for Free Aimmune Therapeutics, Inc. (AIMT) Stock Analysis Report >>
 
To read this article on Zacks.com click here.
 
Zacks Investment Research